Cytovale logo

Cytovale

At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.

121 employees · est. 2013 · South San Francisco, United...

VS
Loop Dx logo

Loop Dx

Cell-mediated immune response diagnostics to predict sepsis early, enabling timely treatment and saving lives.

12 employees · est. 2018 · Barcelona, Spain

Cytovale is the older company (2013 vs 2018); Cytovale is the larger of the two.

Side-by-Side Comparison

Cytovale Loop Dx
Founded
2013 older 2018
Headquarters
South San Francisco, United States Barcelona, Spain
Employees
121 larger 12
Industry
AI, Health Care, Life Sciences Health Care
Funding Stage
Series C Seed
Total Funding
$128.59M $30.00K
Funding Rounds
9 1
Services
Not tracked yet Development of diagnostic tools for sepsis, Early detection of bloodstream infections
Target Customers
Not tracked yet Healthcare providers, Hospitals, Clinical laboratories
Taxonomy
Medical Diagnostics, Cell Mechanics, Sepsis Diagnosis, Immune-mediated Diseases, Early Detection Technologies, Biomechanical Evaluation, FDA Cleared, Rapid Diagnostics, San Francisco-based Company, Immune Response, Critical Care, Sepsis Mortality Cell-mediated Immune Response Diagnostics, Sepsis Detection, Rapid Diagnostics, IVD Company, Innate Immune System Analysis, Severe Bacterial Infection Identification, Critical Care Diagnostics, Point-of-care Testing, Antibiotic Stewardship, Health Economic Validation, CE IVDR Class C Compliance, Clinical Utility In High-risk Patients, Immunology, Sepsis Management Optimization, Healthcare Innovation
Website
cytovale.com loopdx.com
Cytovale logo

About Cytovale

Cytovale: Cytovale, a medical diagnostics company founded in 2013, is focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Their FDA cleared IntelliSep test pioneers a new way of quickly and accurately analyzing white blood cells to stratify a pa...

Loop Dx logo

About Loop Dx

Loop Dx is a pioneering Health Care startup based in Spain focused on creating innovative diagnostics to enhance early-stage sepsis detection. Founded in 2018, the company has developed the SeptiLoop, a CE IVDR Class C near-patient test, which leverages cell-mediated immune response diagnostics for...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Cytovale and Loop Dx — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Cytovale and Loop Dx — by email.

Frequently Asked Questions

Cytovale — At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases. . Loop Dx — Cell-mediated immune response diagnostics to predict sepsis early, enabling timely treatment and saving lives.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cytovale has raised $128.59M while Loop Dx has raised $30.00K.
Cytovale and Loop Dx operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cytovale with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy